ImmunoPrecise Antibodies (OTCMKTS:IPATF) Trading Up 9.3% – Time to Buy?

ImmunoPrecise Antibodies Ltd. ( OTCMKTS:IPATF – Get Free Report ) shares traded up 9.3% on Friday .

The stock traded as high as $0.45 and last traded at $0.45.



285,512 shares traded hands during mid-day trading, an increase of 1,305% from the average session volume of 20,327 shares. The stock had previously closed at $0.41.

ImmunoPrecise Antibodies Stock Performance The company’s 50 day moving average price is $0.42 and its two-hundred day moving average price is $0.66.

ImmunoPrecise Antibodies Company Profile ( Get Free Report ) ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes.

Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization. Featured Stories Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter .

.